AbbVie Inc (ABBV)
182.10
+1.75
(+0.97%)
USD |
NYSE |
Mar 28, 16:00
182.14
+0.04
(+0.02%)
Pre-Market: 20:00
AbbVie Total Liabilities (Quarterly): 124.31B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 124.31B |
September 30, 2023 | 124.09B |
June 30, 2023 | 122.47B |
March 31, 2023 | 121.24B |
December 31, 2022 | 121.52B |
September 30, 2022 | 125.30B |
June 30, 2022 | 128.50B |
March 31, 2022 | 126.90B |
December 31, 2021 | 131.09B |
September 30, 2021 | 135.28B |
June 30, 2021 | 135.38B |
March 31, 2021 | 136.77B |
December 31, 2020 | 137.47B |
September 30, 2020 | 134.33B |
June 30, 2020 | 134.80B |
March 31, 2020 | 98.61B |
December 31, 2019 | 97.29B |
September 30, 2019 | 67.67B |
June 30, 2019 | 65.71B |
March 31, 2019 | 64.60B |
December 31, 2018 | 67.80B |
September 30, 2018 | 69.08B |
June 30, 2018 | 65.02B |
March 31, 2018 | 65.79B |
December 31, 2017 | 65.69B |
Date | Value |
---|---|
September 30, 2017 | 62.15B |
June 30, 2017 | 60.98B |
March 31, 2017 | 60.67B |
December 31, 2016 | 61.46B |
September 30, 2016 | 60.16B |
June 30, 2016 | 61.57B |
March 31, 2016 | 49.08B |
December 31, 2015 | 49.10B |
September 30, 2015 | 49.97B |
June 30, 2015 | 48.35B |
March 31, 2015 | 25.32B |
December 31, 2014 | 25.77B |
September 30, 2014 | 23.81B |
June 30, 2014 | 23.83B |
March 31, 2014 | 23.96B |
December 31, 2013 | 24.71B |
September 30, 2013 | 24.68B |
June 30, 2013 | 24.35B |
March 31, 2013 | 24.21B |
December 31, 2012 | 23.64B |
September 30, 2012 | 7.061B |
June 30, 2012 | 6.204B |
March 31, 2012 | 6.911B |
December 31, 2011 | 7.589B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
64.60B
Minimum
Mar 2019
137.47B
Maximum
Dec 2020
116.67B
Average
124.81B
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 90.92B |
Gilead Sciences Inc | 39.38B |
Immunogen Inc (DELISTED) | 260.50M |
Johnson & Johnson | 98.78B |
Eli Lilly and Co | 53.14B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 134.71B |
Shareholders Equity (Quarterly) | 10.36B |
Debt to Equity Ratio | 5.732 |
Current Ratio | 0.8721 |
Net Debt Paydown Yield | 0.75% |